{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:37:46Z","timestamp":1784763466948,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clgc.2025.102345","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T15:43:26Z","timestamp":1743954206000},"page":"102345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1901-050X","authenticated-orcid":false,"given":"Colin","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrisha-Jade","family":"Inderjeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-9790","authenticated-orcid":false,"given":"Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-2838","authenticated-orcid":false,"given":"Jane","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelyn","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6482-9681","authenticated-orcid":false,"given":"Andrew","family":"Weickhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Parente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-4111","authenticated-orcid":false,"given":"Annabel","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-4580","authenticated-orcid":false,"given":"Anthony","family":"Joshua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-3339","authenticated-orcid":false,"given":"Christopher","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5282-5683","authenticated-orcid":false,"given":"Julie","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1423-4484","authenticated-orcid":false,"given":"Peter","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7350-5622","authenticated-orcid":false,"given":"Arun A.","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clgc.2025.102345_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clgc.2025.102345_bib0002","article-title":"Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019","volume":"2","author":"Zhao","year":"2023","journal-title":"BMJ Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102345_bib0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/cncr.32498","article-title":"Prostate cancer in young men: an emerging young adult and older adolescent challenge","volume":"126","author":"Bleyer","year":"2020","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2025.102345_bib0004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrurol.2014.91","article-title":"Prostate cancer in young men: an important clinical entity","volume":"11","author":"Salinas","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"18","key":"10.1016\/j.clgc.2025.102345_bib0005","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1002\/cam4.3320","article-title":"Clinicopathological characteristics of localized prostate cancer in younger men aged \u2264 50 years treated with radical prostatectomy in the PSA era: a systematic review and meta-analysis","volume":"9","author":"Zheng","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2025.102345_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2018.06.048","article-title":"Younger men with prostate cancer have lower risk of upgrading while on active surveillance: a meta-analysis and systematic review of the literature","volume":"121","author":"Mahran","year":"2018","journal-title":"Urology"},{"issue":"13","key":"10.1016\/j.clgc.2025.102345_bib0007","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/cancers15133509","article-title":"Early onset metastatic colorectal cancer: current insights and clinical management of a rising condition","volume":"15","author":"Medici","year":"2023","journal-title":"Cancers"},{"issue":"SUPPL 7","key":"10.1016\/j.clgc.2025.102345_bib0008","first-page":"54","article-title":"Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer. Asia-Pac J Clin Oncol. Conference: Australian and New Zealand Urogenital and Prostate Cancer Trials Group, ANZUP 2021","volume":"17","author":"Knox","year":"2021","journal-title":"Virtual"},{"issue":"6","key":"10.1016\/j.clgc.2025.102345_bib0009","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ccell.2018.10.016","article-title":"Molecular evolution of early onset prostate cancer identifies molecular risk markers and clinical trajectories","volume":"34","author":"Gerhauser","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.clgc.2025.102345_bib0010","first-page":"50","article-title":"Prostate cancer in young men represents a distinct clinical phenotype: gene expression signature to predict early metastases","volume":"5","author":"Ding","year":"2021","journal-title":"J Transl Genet Genomics"},{"issue":"5","key":"10.1016\/j.clgc.2025.102345_bib0011","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer Tomasz","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.clgc.2025.102345_bib0012","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono Johann","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.clgc.2025.102345_bib0013","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.3390\/cancers14174131","article-title":"Leveraging comprehensive cancer registry data to enable a broad range of research, audit and patient support activities","volume":"14","author":"Lee","year":"2022","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.clgc.2025.102345_bib0014","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer","volume":"34","author":"Halabi","year":"2016","journal-title":"J Clin Oncol"},{"issue":"16_suppl","key":"10.1016\/j.clgc.2025.102345_bib0015","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.16_suppl.e17085","article-title":"Outcomes of patients (pts) with de novo metastatic hormone-sensitive prostate cancer (mHSPC) who progressed to metastatic castration-resistant prostate cancer (mCRPC): a post-hoc analysis of the TRUMPET registry","volume":"41","author":"Shevrin","year":"2023","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102345_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20319-z","article-title":"Time to castration resistance is a novel prognostic factor of cancer-specific survival in patients with nonmetastatic castration-resistant prostate cancer","volume":"12","author":"Hakozaki","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.clgc.2025.102345_bib0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11864-017-0463-3","article-title":"The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment","volume":"18","author":"Connell","year":"2017","journal-title":"Curr Treat Options Oncol."}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:25:07Z","timestamp":1754551507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1558767325000461"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102345","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102345"}}